Eli Lilly, Pfizer Urge Fed. Circ. To Undo Sanofi IP Ruling
Eli Lilly and Co. and Pfizer Inc. have thrown their support behind Sanofi SA and its partner Regeneron Pharmaceuticals in a Federal Circuit case over patents for a cholesterol-lowering drug, saying...To view the full article, register now.
Already a subscriber? Click here to view full article